CX 2024 Preliminary Programme

Showing the latest CX 2024 Programme, talks, speakers and timings subject to change.
The organisers reserve the right to alter the programme as necessary.
All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter the timings if necessary.

Day 2 Morning: Juxtarenal Controversies - Wednesday, 24th April
Venue:   Theatre 1
Juxtarenal Controversies
Podium First: Aneurysm-sac dynamics and its prognostic significance following fenestrated/branched EVAR
Speaker:   Hence Verhagen, Rotterdam, Netherlands
Audience participation & discussion
Long-term mortality and reintervention after EVAR vs. OAR in Australia, Germany, and the United States
Speaker:   Christian-Alexander Behrendt, Hamburg, Germany
Audience participation & discussion
ESAR versus FEVAR in patients with short-neck abdominal aortic aneurysm
Speaker:   Antoine Millon, Lyon, France
Audience participation & discussion
Podium First: A new endoanchor system for enhanced endograft fixation and seal
Speaker:   Andrew Holden, Auckland, New Zealand
Audience participation & discussion
Edited Case: Low profile devices for complex endovascular repairs with aortoiliac occlusive disease
Speaker:   Luca Bertoglio, Brescia, Italy
Audience participation & discussion
 
Sponsored education
Juxtarenal Controversies (Continued)
Moderator:   TBA
Freedom from seal zone complication and sac regression are true metrics of success in hostile juxtarenal AAA
Speaker:   Apostolos Tassiopoulos, East Setauket, United States
Audience participation & discussion
Great Debate: The best treatment for most juxtarenal AAA is… FEVAR - TBC ESAR - Ross Milner OR - Dittmar Boeckler
Faculty:   Ross Milner, Chicago, United States
Dittmar Boeckler, Heidelberg, Germany
Audience participation & discussion
 
Advanced Imaging and Reducing Radiation
Podium First: Operator position influences radiation dose: A phantom study
Speaker:   Fiona Rohlffs, Hamburg, Germany
Audience participation & discussion
Evidence for radiation induced DNA damage in patients after EVAR: The role of radiation sparing technologies
Speaker:   Bijan Modarai, London, United Kingdom
Audience participation & discussion
Edited Case: Surgical augmented intelligence maps to support aortoiliac occlusive disease
Speaker:   Jan Heyligers, Tilburg, Netherlands
Audience participation & discussion
Update on new imaging technologies for aortic disease diagnosis and follow-up
Speaker:   Catharina van Rijswijk, Leiden, Netherlands
Audience participation & discussion
 
Sponsored education
Day 2 Afternoon: Abdominal Aortic Aneurysm Controversies
Venue:   Theatre 1
Abdominal Aortic Aneurysm Controversies
Great Debate: Volume-outcome relationship of AAA repair calls for a combined recommendation of EVAR and OAR hospital volumes

For the motion
Kevin Mani, Uppsala, Sweden

Against the motion
David Stone, Lebanon, United States
Grace Wang, Merion Station, United States

Audience participation & discussion
What is new on the 2024 AAA guidelines
Audience participation & discussion
Core outcomes, cognitive function and secondary rupture risk after AAA repair
Speaker:   Janet Powell, London, United Kingdom
Audience participation & discussion
Growth preventive therapy for AAA: A first-in-human study
Speaker:   Andrew Holden, Auckland, New Zealand
Audience participation & discussion
Mid-term outcomes of a conformable EVAR device in challenging aortic necks
Speaker:   Jean Paul de Vries, Groningen, Netherlands
Audience participation & discussion
Update on a novel abdominal aortic stent graft system and sac regression
Speaker:   Michael Stoner, Rochester, United States
Audience participation & discussion
Podium First: One-year outcomes of fenestrated ringstent based endografts: the Global Fact Registry
Speaker:   Michel Reijnen, Arnhem, Netherlands
Audience participation & discussion
 
Sponsored education
Abdominal Aortic Aneurysm Controversies (Continued)
Debate: New polymer-based aneurysm sac management is the future and differs from previously failed polymer-based technologies

For the motion
Andrew Holden, Auckland, New Zealand

Against the motion
Robert Morgan, London, United Kingdom

Audience participation & discussion
Sarcopenia and outcomes of AAA intervention
Speaker:   Alun Davies, London, United Kingdom
Audience participation & discussion
Podium First: Post market experience with an abdominal stent graft system: JAGUAR Trial Update
Speaker:   Sean Lyden, Cleveland, United States
Audience participation & discussion
Podium First: Long term outcome of the ICEBERG study
Speaker:   Michel Reijnen, Arnhem, Netherlands
Audience participation & discussion
 
Endovascular Aneurysm Repair Follow Up
Podium First: Long-term health-related quality of life after acute type B aortic dissection: A cross-sectional survey study
Speaker:   Hence Verhagen, Rotterdam, Netherlands
Audience participation & discussion
Survey on diagnosis, management and prevention of type II endoleak
Speaker:   Kevin Mani, Uppsala, Sweden
Audience participation & discussion
Long-term outcomes of embolisation of type I endoleaks post EVAR
Speaker:   Robert Morgan, London, United Kingdom
Audience participation & discussion